Prothena Corporation plc (PRTA) Financials

PRTA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 349.9 million 37.3 million
Dec. 31, 2025 326.8 million 46.3 million
Sept. 30, 2025 352.6 million 57.6 million
June 30, 2025 399.1 million 74.7 million

PRTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 28.9 million 6.9 million
Dec. 31, 2025 -23.3 million 7.1 million
Sept. 30, 2025 -40.6 million 7.2 million
June 30, 2025 -46.4 million 12.4 million

PRTA Net Income

No data available :(

PRTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 329.5 million 4.8 million -
Dec. 31, 2025 307.5 million 5.5 million 5.5 million
Sept. 30, 2025 330.8 million - 9.1 million
June 30, 2025 371.4 million - 9.8 million

PRTA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 54.1 million
Dec. 31, 2025 53.8 million
Sept. 30, 2025 53.8 million
June 30, 2025 53.8 million

PRTA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 12.6 million 12.7 million -
Dec. 31, 2025 4939 14.6 million 12.6 million -
Sept. 30, 2025 10000 28.9 million 13.2 million -
June 30, 2025 86000 40.5 million 15.9 million -

PRTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 51.1 million 918000
Dec. 31, 2025 21000 942000
Sept. 30, 2025 2.4 million 28.9 million
June 30, 2025 4.4 million -

PRTA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PRTA

Price: $9.25

52 week price:
4.76
11.80

Earnings Per Share: -2.81 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Ireland

Volume: 314000

Ebitda: -47.3 million

Market Capitalization: 484.3 million

Links: